Goldman upgraded its target price by 25% to A$0.75 this morning. Analysts will undoubtedly have to continue to chase RBL higher with their px targets going forward. This is a great scenario for some longer-term gains now that we are in the upgrade cycle.
Management mentioned in the recent quarterly that April traffic was strong and Google trends would indicate this has continued into May.
Between Blackrock going substantial and Perennial increasing to +10% of the register during March/April their cant be much loose stock left.
Take over premium for RBL will also return once things settle down.
Plenty of good things happening here
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder
Goldman upgraded its target price by 25% to A$0.75 this morning....
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATG (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.8¢ |
Change
-0.003(0.64%) |
Mkt cap ! $109.2M |
Open | High | Low | Value | Volume |
38.5¢ | 39.0¢ | 38.0¢ | $36.60K | 95.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3130 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 1602 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3130 | 0.385 |
4 | 28899 | 0.380 |
2 | 10669 | 0.375 |
3 | 68008 | 0.370 |
2 | 2492 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 1602 | 2 |
0.395 | 61761 | 2 |
0.400 | 90371 | 5 |
0.415 | 11670 | 3 |
0.425 | 18337 | 3 |
Last trade - 14.40pm 15/07/2024 (20 minute delay) ? |
Featured News
ATG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online